** Medical device maker Microbot Medical's MBOT.O shares up 50% at $2.08
** MBOT says its experimental endovascular robotic system, Liberty, met main goal in the study
** Endovascular robotic system assists doctors on minimally invasive surgeries inside blood vessels for treating aneurysms, blockages and other vascular issues
** "Mean difference in radiation exposure between operator and control was (-)29.8 µS, resulting in a mean 92% relative reduction in radiation exposure" - MBOT
** Some robotic systems use radiation-based imaging techniques, like X-rays or gamma rays
** Company says no adverse device events were reported during the study
** Up to last close, stock has risen 24.1% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。